Baldwin Brothers LLC Invitae Corp Transaction History

Baldwin Brothers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	BUY	$6.28 - $15.59 $1,029 - $2,556	164 Added 65.86%	413 $3,000
Q4 2021 Jan 14, 2022	SELL	$14.7 - $28.67 $11,760 - $22,936	-800 Reduced 76.26%	249 $4,000
Q3 2021 Oct 27, 2021	BUY	$24.31 - $33.6 $6,053 - $8,366	249 Added 31.13%	1,049 $30,000
Q1 2021 Apr 08, 2021	BUY	$33.06 - $56.93 $26,448 - $45,544	800 New	800 $31,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

Stay updated on Baldwin Brothers LLC with notifications on news.